IDENTIFICATION OF 2 TRANSCRIPTS OF AMLI/ETO-FUSED GENE IN T(8-21) LEUKEMIC-CELLS AND EXPRESSION OF WILD-TYPE ETO GENE IN HEMATOPOIETIC-CELLS

被引:39
作者
ERA, T
ASOU, N
KUNISADA, T
YAMASAKI, H
ASOU, H
KAMADA, N
NISHIKAWA, SI
YAMAGUCHI, K
TAKATSUKI, K
机构
[1] KUMAMOTO UNIV,SCH MED,BLOOD TRANSFUS SERV,KUMAMOTO 860,JAPAN
[2] KYOTO UNIV,FAC MED,DEPT MOLEC GENET,KYOTO,JAPAN
[3] HIROSHIMA UNIV,NUCL MED & BIOL RES INST,DEPT HEMATOL,HIROSHIMA,JAPAN
关键词
D O I
10.1002/gcc.2870130105
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The t(8;21) is a common chromosomal abnormality, preferentially associated with acute leukemia showing features of myeloid differentiation. Recently, two genes-AMLI, which has a unique runt domain, and ETO (MTG8)-have been isolated from the chromosomal breakpoint. In this study, we isolated and identified two fused transcripts from a leukemic cell line carrying t(8;21). AMLI and ETO were fused at the same position in these transcripts. One of the transcripts codes a unique domain, including two zinc finger domains and three proline- and one leucine-rich region. The other transcript codes only for one proline- and leucine-rich region but lacks zinc finger domains. We demonstrated by polymerase chain reaction (PCR) analysis that I) these two transcripts are consistently expressed in leukemic cells with t(8;21) obtained from patients and 2) expression of AML I was not restricted to the particular stage of hematopoietic differentiation but was present in all hematopoietic cells investigated. We also provide evidence that two wild types of ETO transcripts containing the region of the ETO gene in fused transcripts are expressed in hematopoietic cells from different lineages. The widespread expression of AMLI and ETO in hematopoietic cells suggests a fundamental role of these proteins in hematopoiesis. Furthermore, the differences in the carboxy termini of ETO may modulate the activity of fused proteins resulting from the chromosomal translocation t(8;21). (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 53 条
  • [1] Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N, Establishment of a human acute myeloid leukemia cell line (Kasumi‐1) with 8
  • [2] 21 chromosome translocation, Blood, 77, pp. 2031-2036, (1991)
  • [3] Bae SC, Yamaguchi-Iwai Y, Ogawa E, Maruyama M, Inuzuka M, Kagoshima H, Shigesada K, Satake M, Ito Y, Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AMLI, Oncogene, 8, pp. 809-814, (1993)
  • [4] Bae SC, Ogawa E, Maruyama M, Oka H, Satake M, Shigesada K, Jenkins NA, Gilbert DJ, Copeland NG, Ito Y, PEBP2αB/mouse AMLI consists of multiple isoforms that possess differential transactivation potentials, Mol Cell Biol, 14, pp. 3242-3252, (1994)
  • [5] Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR, Sultan C, Proposals for the classification of the acute leukaemias, Br J Haematol, 33, pp. 451-458, (1976)
  • [6] Bennett JM, Catovsky D, Daniel MT, Flandrin G, Gallon DAG, Gralnick HR, Sultan C, Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French‐American‐British Cooperative Group, Ann Intern Med, 103, pp. 620-625, (1985)
  • [7] Dawning JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS, Civin CI, Erickson P, An AML1/ETO fusion transcript is consistently deteced by RNA‐based polymerase chain reaction in acute myelogenous leukemia containing the t(8
  • [8] 21)(q22
  • [9] q22) translocation, Blood, 81, pp. 2860-2865, (1993)
  • [10] Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo JM, Rowley J, Drabkin H, Identification of breakpoints in t(8